Price
No data yet.
Social Signal Score
Analyst Ratings
1 analystRevenue
$589.00M+44.40%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Michael S. Simmons
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 2,826
- Beta
- 1.11
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 1.90
Financials
Revenue
$589.00M+44.4%Net Income
$30.20M+231.9%EBITDA
$62.60M+1.3%Free Cash Flow
$43.60M+124.7%EPS (diluted)
$1.06+194.4%Shares Outstanding (diluted)
28.60M+0.4%Operating Expenses
$82.00MCash & Debt
$219.80MReturn of Capital
$2.30MRevenue by Segment (annual)
$2.08BDividend per Share
$0.08Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.08B | $-57.60M | $-2.02 |
| 2024 | $2.10B | $108.00M | $3.79 |
| 2023 | $1.92B | $-9.90M | $-0.42 |
| 2022 | $2.22B | $87.20M | $3.16 |
| 2021 | $2.30B | $127.20M | $4.46 |
| 2020 | $1.85B | $55.20M | $1.94 |
| 2019 | $1.90B | $49.20M | $2.74 |
| 2018 | $1.82B | $262.20M | $9.20 |
| 2017 | $1.88B | $207.50M | $7.32 |
| 2016 | $1.57B | $-15.90M | $-0.56 |
| 2015 | $1.53B | $-133.60M | $-4.73 |
| 2014 | $1.86B | $53.80M | $1.92 |
| 2013 | $1.86B | $-98.00M | $-3.48 |
| 2012 | $2.09B | $159.80M | $5.64 |
Valuation
VHIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
120+50.00%Social Signal Score
Mentions (6)
- Newsmarketbeat.com·9d ago·Positive
What Vitalhub (VHI) Said on Its Q3 Earnings Call Vitalhub TSE: VHI reported a higher third-quarter profit and its strongest adjusted EBITDA margin in two years, even as revenue remained flat and uncertainty surrounding its SHREWD business weighed on annual recurring revenue growth.
View source ↗ - Newszacks.com·12d ago·Neutral
VHI Stock Gains 6.7% as Q3 Earnings Rebound on Chemicals Growth Valhi's Q3 earnings rebound as stronger Chemicals sales, improved pricing and cost reductions boost profitability despite weaker real estate results.
View source ↗ - Newsseekingalpha.com·13d ago·Negative
Valhi: Chloride Advantage Clear, But Might Be Fading Valhi trades at a steep ~50% NAV discount, but consistent with more recent historical averages. Chloride process margins improved due to higher TiO2 prices and surging costs for sulphate-process competitors, but this advantage appears to be fading as sulphur prices fall. End-market demand, especially in US construction and European markets, remains muted, raising concerns about sustained volume and pricing strength.
View source ↗ - Newsglobenewswire.com·19d ago·Neutral
VitalHub Announces Q3 2026 Conference Call Date TORONTO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today that it will release financial results for the third quarter 2026 ended September 30, 2026 after market close on November 12, 2026. The Company will subsequently hold a conference call on November 13, 2026, at 9:00am ET, hosted by CEO Dan Matlow and CFO Brian Goffenberg with a Q&A session to follow.
View source ↗ - Newsglobenewswire.com·39d ago·Negative
VALHI ANNOUNCES EXPECTED THIRD QUARTER 2026 EARNINGS RELEASE DATE Dallas, Texas, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) announced today that, subject to the completion of quarter-end closing procedures, it expects to report third quarter 2026 earnings in a press release after market close on Thursday, November 5, 2026.
View source ↗ - Newszacks.com·101d ago·Neutral
Valhi Q2 Earnings Surge Y/Y as Chemical Volumes, Margins Improve VHI's Q2 earnings jump y/y as higher TiO2 volumes, lower costs and wider margins lift the results, supporting an improved 2026 operating outlook.
View source ↗
Earnings
Thu, Mar 11(in 4 months)
Consensus estimate $0.89 per share
Typical surprise -90.9% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Nov 5$1.06 vs $0.85beat
- Thu, Aug 6$0.78 vs $0.96miss
- Thu, May 7$0.07 vs $0.77miss
- Tue, Mar 10$-1.86 vs $0.86miss
- Thu, Nov 6$-0.78 vs $0.83miss
- Thu, Aug 7$0.03 vs $0.76miss
Estimates and results for VHI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by VHI officers and directors.
- Bought
- $90k
- Sold
- $33k
12 trades
1 trade
- Hanley Bryan A.bought
- Samford Amy A.bought
- Graham Robert Dbought
- Graham Robert Dbought
- Graham Robert Dbought
- Hanley Bryan A.bought
- Hanley Bryan A.bought
- Hanley Bryan A.bought
87 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in VHI.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
